George Scangos

2020

In 2020, George Scangos earned a total compensation of $994.9K as President and Chief Executive Officer at Vir Biotechnology, a 75% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$438,900
Salary$544,583
Other$11,400
Total$994,883

Scangos received $544.6K in salary, accounting for 55% of the total pay in 2020.

Scangos also received $438.9K in non-equity incentive plan and $11.4K in other compensation.

Rankings

In 2020, George Scangos' compensation ranked 8,672nd out of 13,090 executives tracked by ExecPay. In other words, Scangos earned more than 33.8% of executives.

ClassificationRankingPercentile
All
8,672
out of 13,090
34th
Division
Manufacturing
3,692
out of 5,621
34th
Major group
Chemicals And Allied Products
1,492
out of 2,254
34th
Industry group
Drugs
1,300
out of 1,954
34th
Industry
Biological Products, Except Diagnostic Substances
305
out of 411
26th
Source: SEC filing on April 6, 2021.

Scangos' colleagues

We found four more compensation records of executives who worked with George Scangos at Vir Biotechnology in 2020.

2020

Steven Rice

Vir Biotechnology

Chief Administrative Officer

2020

Howard Horn

Vir Biotechnology

Chief Financial Officer

2020

Herbert Virgin

Vir Biotechnology

Chief Scientific Officer

2020

Michael Kamarck

Vir Biotechnology

Chief Technology Officer

News

You may also like